SCHEMBL7763446

SCHEMBL7763446

CCCN(CCC)C1CCc2cccc(C(=O)CC)c2C1

nearest known ligand 0.81

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.67
HTR7 P34969 3/20 0.67
DRD2 P14416 2/20 0.67
HTR1D P28221 2/20 0.67
DRD3 P35462 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP2D6 P10635 1/20 0.67
TSHR P16473 1/20 0.67
HTR1B P28222 1/20 0.67
HTR2A P28223 1/20 0.67
HTR2C P28335 1/20 0.67
ADRA1A P35348 1/20 0.67
ADRA1B P35368 1/20 0.67
HTR2B P41595 1/20 0.67
HTR5A P47898 1/20 0.67
BLM P54132 1/20 0.65
ALDH1A1 P00352 1/20 0.65
LMNA P02545 1/20 0.65
PMP22 Q01453 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7768095 1.00 HTR1A (0.67) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7768660 0.91 HTR1A (0.65) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL8904245 0.90 HTR1A (0.70) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL8822510 0.89 HTR1A (0.64) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7763436 0.89 HTR1A (0.68) HTR1AHTR7DRD2HTR1DDRD3
Hydrochloric Acid SCHEMBL8904219 0.89 HTR1A (0.68) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL8822536 0.88 HTR1A (0.61) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7768623 0.88 HTR1A (0.61) HTR1AHTR7DRD2HTR1DDRD3
SCHEMBL7932899 0.88 HTR1A (0.67) HTR1AHTR7DRD2HTR1DDRD3
Hydrochloric Acid SCHEMBL8822572 0.88 HTR1A (0.67) HTR1AHTR7DRD2HTR1DDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0579507-B1 Isoxazole derivatives for the treatment of irritable bowel syndrome LILLY CO ELI (US) 2001-10-17 EP disclosed
EP-0712837-B1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes LILLY CO ELI (US) 2000-10-25 EP disclosed
EP-0498590-B1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes LILLY CO ELI (US) 1997-04-09 EP disclosed
EP-0471515-B1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes LILLY CO ELI (US) 1997-03-05 EP disclosed
US-5571942-A Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes ELI LILLY AND COMPANY (US) 1996-11-05 US disclosed
US-5552444-A AGONIST ACTIVITY AT SEROTONIN RECEPTORS, ANTIDEPRESSANTS ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0712837-A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes ELI LILLY AND COMPANY (US) 1996-05-22 EP disclosed
US-5470977-A Serotonin 1A receptor agonists ELI LILLY AND COMPANY (US) 1995-11-28 US disclosed
US-5466709-A Serotonin receptors ELI LILLY AND COMPANY (US) 1995-11-14 US disclosed
US-5434174-A Administering 5-hydroxytryptamine agonist; gastrointestinal disorders ELI LILLY AND COMPANY (US) 1995-07-18 US disclosed
US-5426226-A Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes HOECHSTETTER CRAIG S (US) 1995-06-20 US disclosed
US-5426229-A Treatment of sleep, sex, memory and appetite disorders depression, and anxiety; serotinin inhibitors ELI LILLY AND COMPANY (US) 1995-06-20 US disclosed
US-5286753-A Serotonin 1a receptor agonists ELI LILLY AND COMPANY (US) 1994-02-15 US disclosed
EP-0579507-A1 Isoxazole derivatives for the treatment of irritable bowel syndrome ELI LILLY AND COMPANY (US) 1994-01-19 EP disclosed
EP-0498590-A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes ELI LILLY AND COMPANY (US) 1992-08-12 EP disclosed
EP-0471515-A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes ELI LILLY AND COMPANY (US) 1992-02-19 EP disclosed